[{"Assets_0_Q2_USD":10216367000.0,"CIK":"875320","CommonStockSharesConverted_0_Q2_shares":260124000.0,"CommonStockSharesOutstanding_0_Q2_shares":260124000.0,"Country":"United States","EarningsPerShareBasic_1_Q2_USD":3.22,"EarningsPerShareBasic_2_Q2_USD":5.54,"EarningsPerShareDiluted_1_Q2_USD":3.18,"EarningsPerShareDiluted_2_Q2_USD":5.46,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1854225000.0,"NetIncomeLossConverted_1_Q2_USD":837270000.0,"NetIncomeLossConverted_2_Q2_USD":1440023000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q2_USD":1524485000.0,"RevenuesConverted_2_Q2_USD":3039592000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":7519242000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":263403000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":263746000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":259637000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":260013000.0,"filed":"20200731","footnote":"nan","form":"10-Q","fp":"Q2","fy":"2020.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20200630","qtrs":"2","uom":"USD"}]